If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Company Board Changes

16 Jul 2024 10:49

RNS Number : 6025W
Mandarin Oriental International Ltd
16 July 2024
Β 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Β 

COMPANY BOARD CHANGES

Β 

Β 

Mandarin Oriental International Limited (the 'Company') is pleased to announce the following changes to the Board:

Β 

Fabrice Megarbane will join the Board of the Company as an Independent Non-Executive Director with effect from 1 August 2024.

Β 

John Witt, Group Managing Director of Jardine Matheson, will step down as a Director from the Company's Board and as a member of the Remuneration and Nominations Committees. Adam Keswick will step down from the Nominations Committee and Graham Baker will step down from the Remuneration Committee. Adam remains as a Director. These changes will all take effect from 22 July 2024.

Β 

The Company is also announcing that Sean Ward will be appointed as Company Secretary, with effect from 22 July 2024, succeeding Jonathan Lloyd.

Β 

Fabrice Megarbane is the Chief Global Growth Officer of L'OrΓ©al. He was previously President and CEO of L'OrΓ©al North Asia and CEO of L'OrΓ©al China and serves on its global executive committee. He managed a combined revenue of more than EUR10 billion, which accounts for over 25 percent of L'OrΓ©al's global business, and an organisation of 20,000 people. Fabrice started his marketing career at L'OrΓ©al S.A. in 2000. He brings multi-market experience, combining emerging and developed markets, including Europe, the Middle East, Africa, Germany, China and now North Asia.

Β 

Commenting on these changes, Chair Ben Keswick said: "I am pleased to welcome Fabrice to our Board, which will benefit from his extensive experience at L'OrΓ©al. He is an accomplished and passionate marketer and brand builder with a deep consumer focus and extensive experience in digital transformation.

Β 

We will continue to enhance the composition of our Board, bringing in relevant expertise to help our management team deliver on their strategy and build long-term shareholder value.

Β 

I would also like to thank John and Jonathan for their service to the Board."

Β 

Β 

Jonathan Lloyd, Jardine Matheson LimitedFor and on behalf of Mandarin Oriental International Limited

Β 

16th July 2024

Β 

www.mandarinoriental.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAGPUBCMUPCUBQ
Date   Source Headline
9th May 201212:32 pmRNSInterim Management Statement
3rd May 201212:21 pmRNSAnnual Information Update
2nd May 201210:48 amRNSDividend
30th Apr 20121:06 pmRNSTotal Voting Rights
27th Apr 201211:00 amRNSDirector Declaration
11th Apr 201210:10 amRNSAnnual Financial Report
3rd Apr 201212:00 pmRNSDirector/PDMR Shareholding
2nd Apr 201212:13 pmRNSDirector Declaration
30th Mar 201210:50 amRNSTotal Voting Rights
26th Mar 201212:15 pmRNSBlocklisting Interim Review
20th Mar 201211:37 amRNSDirector/PDMR Shareholding
20th Mar 20128:51 amRNSAdditional Listing
19th Mar 201210:28 amRNSDirector/PDMR Shareholding
16th Mar 201210:43 amRNSDirector/PDMR Shareholding
15th Mar 201210:50 amRNSDirector/PDMR Shareholding
14th Mar 201210:31 amRNSDirector/PDMR Shareholding
1st Mar 20129:06 amRNSDirectorate Change and Declaration
1st Mar 20129:06 amRNSFinal Results
6th Feb 201211:20 amRNSNotice of 2011 Final Results
30th Dec 20119:14 amRNSDirectorate Change
9th Nov 20119:10 amRNSInterim Management Statement
31st Oct 201111:13 amRNSTotal Voting Rights
6th Oct 201111:57 amRNSDirector/PDMR Shareholding
3rd Oct 201110:22 amRNSDirector Declaration
29th Sep 201111:15 amRNSDirectorate Change
28th Sep 201110:24 amRNSDividend
26th Sep 201110:21 amRNSBlocklisting Interim Review
28th Jul 201110:05 amRNSHalf Yearly Report
30th Jun 201110:27 amRNSNotice of 2011 Half-Yearly Results
31st May 201110:42 amRNSTotal Voting Rights
12th May 20111:14 pmRNSDirectorate Change
11th May 20112:18 pmRNSAGM Statement
11th May 20112:11 pmRNSResult of AGM
11th May 201112:31 pmRNSInterim Management Statement
5th May 201111:28 amRNSDirector/PDMR Shareholding
4th May 201110:16 amRNSDividend
3rd May 201111:37 amRNSAnnual Information Update
7th Apr 201110:37 amRNSAnnual Financial Report
31st Mar 201110:46 amRNSDirector/PDMR Shareholding
31st Mar 201110:40 amRNSTotal Voting Rights
25th Mar 20119:22 amRNSBlocklisting Interim Review
22nd Mar 20118:54 amRNSAdditional Listing
16th Mar 20119:24 amRNSDirector/PDMR Shareholding
3rd Mar 20119:05 amRNSFinal Results
7th Feb 20119:14 amRNSNotice of 2010 Final Results
31st Dec 20107:12 amRNSTotal Voting Rights
15th Dec 201010:11 amRNSDirector/PDMR Shareholding
14th Dec 20109:37 amRNSDirector/PDMR Shareholding
13th Dec 201010:01 amRNSDirector/PDMR Shareholding
10th Dec 20109:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.